The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2021
Source ID
10.1016/j.jacbts.2020.10.003

Entities

People

  • Brandon J. Beddingfield
  • Chad J Roy
  • Gregory J. Bix
  • Jay K. Kolls
  • Naoki Iwanaga
  • Prem P. Chapagain
  • Tony Hu
  • Wenshu Zheng

Organizations

  • National Center for Research Resources
  • National Institutes of Health
  • United States Department of Defense